{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:47:00Z","timestamp":1785818820311,"version":"3.56.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260325"],"award-info":[{"award-number":["82260325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["24JRRA923"],"award-info":[{"award-number":["24JRRA923"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["25YFFA055"],"award-info":[{"award-number":["25YFFA055"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the mechanism and therapeutic potential of targeting the extracellular signal-regulated kinase 1\/2 (ERK1\/2) signalling pathway in myositis-associated interstitial lung disease, focusing on its role in neutrophil extracellular traps (NETs)-mediated pro-inflammatory and pro-fibrotic processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Lung tissue samples were collected from patients with idiopathic inflammatory myopathy-associated ILD (IIM-ILD) and from mice with experimental autoimmune myositis (EAM) and a myositis-associated interstitial lung disease model (MAILD). Multiple experimental techniques, including immunohistochemistry, western blotting, immunofluorescence and transcriptome sequencing were employed to analyse ERK1\/2 activation, NETs infiltration and the expression of epithelial-mesenchymal transition (EMT)-related markers. The ERK1\/2 inhibitor U0126 was applied both in vivo and in vitro for interventional validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The ERK1\/2 signalling pathway was activated in the lung tissues of IIM-ILD patients and in the EAM and MAILD mouse models. Substantial NETs infiltration was observed in the lung tissues of EAM and MAILD mice. NETs induced EMT and the release of pro-inflammatory factors by activating ERK1\/2. Inhibiting NETs formation attenuated ERK1\/2 phosphorylation and the downstream fibrotic process. Administration of the ERK1\/2 inhibitor U0126 not only effectively alleviated NETs-induced EMT and inflammatory responses but also significantly reduced pulmonary inflammation infiltration and NETs formation in the MAILD model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NETs-mediated pro-inflammatory and pro-fibrotic processes contribute to the progression of myositis-associated interstitial lung disease by activating the ERK1\/2 signalling pathway. Targeting ERK1\/2 effectively inhibits this pathogenic cascade, providing a novel strategy for clinical treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag367","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:46:06Z","timestamp":1784115966000},"source":"Crossref","is-referenced-by-count":0,"title":["Targeting ERK1\/2 attenuates neutrophil extracellular traps-mediated pro-inflammatory and pro-fibrotic effects in myositis-associated interstitial lung disease"],"prefix":"10.1093","volume":"65","author":[{"given":"Hui","family":"Chai","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University , Lanzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Yang","sequence":"additional","affiliation":[{"name":"Cuiying Biomedical Research Center, The Second Hospital of Lanzhou University , Lanzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University , Lanzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cui","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University , Lanzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University , Lanzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Guo","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University , Lanzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lv","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Lanzhou University , Lanzhou,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1565-1431","authenticated-orcid":false,"given":"Sigong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Second Hospital of Lanzhou University , Lanzhou,","place":["China"]},{"name":"Gansu Provincial Clinical Research Center for Rheumatic and Immunologic Diseases , Lanzhou, Gansu,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2026080400365371500_keag367-B1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11926-013-0359-6","article-title":"Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis","volume":"15","author":"Kiely","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"2026080400365371500_keag367-B2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(25)00233-9","article-title":"Advances in the classification and management of idiopathic inflammatory myopathies","volume":"24","author":"Raaphorst","year":"2025","journal-title":"Lancet Neurol"},{"key":"2026080400365371500_keag367-B3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/medicina58121757","article-title":"Clinical and radiological features of interstitial lung diseases associated with polymyositis and dermatomyositis","volume":"58","author":"Palmucci","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"2026080400365371500_keag367-B4","doi-asserted-by":"crossref","first-page":"1288098","DOI":"10.3389\/fimmu.2023.1288098","article-title":"The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and in vivo validation","volume":"14","author":"Zeng","year":"2023","journal-title":"Front Immunol"},{"key":"2026080400365371500_keag367-B5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s13287-025-04597-8","article-title":"Advancements in mesenchymal stromal cells for treating connective tissue disease-associated interstitial lung disease: from basic research to clinical application","volume":"16","author":"Yuan","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"2026080400365371500_keag367-B6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10238-024-01384-2","article-title":"Pathogenic role and clinical significance of neutrophils and neutrophil extracellular traps in idiopathic inflammatory myopathies","volume":"24","author":"Liu","year":"2024","journal-title":"Clin Exp Med"},{"key":"2026080400365371500_keag367-B7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/jcmm.14858","article-title":"Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"2026080400365371500_keag367-B8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ekir.2018.11.005","article-title":"Clinical implications of excessive neutrophil extracellular trap formation in renal autoimmune diseases","volume":"4","author":"van Dam","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2026080400365371500_keag367-B9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4103\/0366-6999.235122","article-title":"Neutrophil extracellular traps in autoimmune diseases","volume":"131","author":"He","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"2026080400365371500_keag367-B10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cei\/uxad059","article-title":"The role of neutrophil extracellular traps and proinflammatory damage-associated molecular patterns in idiopathic inflammatory myopathies","volume":"213","author":"Ma","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"2026080400365371500_keag367-B11","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxae106","article-title":"A novel mouse model of myositis-associated interstitial lung disease was established by using TLR9 agonist combined with muscle homogenate","volume":"219","author":"Bai","year":"2025","journal-title":"Clin Exp Immunol"},{"key":"2026080400365371500_keag367-B12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cei\/uxae028","article-title":"Neutrophil extracellular traps induce pyroptosis of pulmonary microvascular endothelial cells by activating the NLRP3 inflammasome","volume":"217","author":"Zhao","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"2026080400365371500_keag367-B13","doi-asserted-by":"crossref","first-page":"114144","DOI":"10.1016\/j.intimp.2025.114144","article-title":"cGAS-STING mediates neutrophil extracellular traps-induced EMT in myositis-associated interstitial lung disease: STING as a potential therapeutic target","volume":"149","author":"Feng","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"2026080400365371500_keag367-B14","doi-asserted-by":"crossref","first-page":"115431","DOI":"10.1016\/j.intimp.2025.115431","article-title":"Neutrophil extracellular traps mediate macrophage polarization and pyroptosis through the TLR9-NF-\u03baB\/AIM2 pathway exacerbating myositis-associated interstitial lung disease","volume":"165","author":"Cui","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"2026080400365371500_keag367-B15","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/ijms20122885","article-title":"Extracellular-signal regulated kinase: a central molecule driving epithelial\u2013mesenchymal transition in cancer","volume":"20","author":"Olea-Flores","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026080400365371500_keag367-B16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1166\/jbt.2022.2945","article-title":"miR-16 inhibits extracellular signal-regulated kinases (ERK) mitogen-activated protein kinases (MAPK) signaling to affect epithelial-mesenchymal transition (EMT) and invasion of glioma cells","volume":"12","author":"Sun","year":"2022","journal-title":"J Biomater Tissue Eng"},{"key":"2026080400365371500_keag367-B17","first-page":"517","article-title":"EMT and interstitial lung disease: a mysterious relationship","volume":"18","author":"Kage","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"2026080400365371500_keag367-B18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12931-024-02878-z","article-title":"Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis","volume":"25","author":"Zhou","year":"2024","journal-title":"Respir Res"},{"key":"2026080400365371500_keag367-B19","doi-asserted-by":"crossref","first-page":"L241","DOI":"10.1152\/ajplung.00093.2018","article-title":"Inhibition of Raf1 ameliorates bleomycin-induced pulmonary fibrosis through attenuation of TGF-\u03b21 signaling","volume":"315","author":"Li","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026080400365371500_keag367-B20","doi-asserted-by":"crossref","first-page":"791231","DOI":"10.1155\/2013\/791231","article-title":"Inflammatory signalings involved in airway and pulmonary diseases","volume":"2013","author":"Lee","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2026080400365371500_keag367-B21","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.21037\/jtd.2017.09.135","article-title":"Urban particulate matter triggers lung inflammation via the ROS-MAPK-NF-\u03baB signaling pathway","volume":"9","author":"Wang","year":"2017","journal-title":"J Thorac Dis"},{"key":"2026080400365371500_keag367-B22","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1007\/s10753-024-02220-1","article-title":"Colchicine alleviates interstitial lung disease in an experimental autoimmune myositis murine model by inhibiting the formation of neutrophil extracellular traps","volume":"48","author":"Li","year":"2025","journal-title":"Inflammation"},{"key":"2026080400365371500_keag367-B23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cei\/uxad104","article-title":"Neutrophil extracellular traps are involved in the occurrence of interstitial lung disease in a murine experimental autoimmune myositis model","volume":"215","author":"Bai","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"2026080400365371500_keag367-B24","doi-asserted-by":"crossref","first-page":"e2812","DOI":"10.1038\/cddis.2017.52","article-title":"The role of extracellular histone in organ injury","volume":"8","author":"Silk","year":"2017","journal-title":"Cell Death Dis"},{"key":"2026080400365371500_keag367-B25","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxaf019","article-title":"Pirfenidone alleviates interstitial lung disease in mice by inhibiting neutrophil extracellular trap formation and NLRP3 inflammasome activation","volume":"219","author":"Su","year":"2025","journal-title":"Clin Exp Immunol"},{"key":"2026080400365371500_keag367-B26","first-page":"632","article-title":"Biomechanical properties of epithelial mesenchymal transition in idiopathic pulmonary fibrosis (In Chinese)","volume":"40","author":"Li","year":"2023","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"key":"2026080400365371500_keag367-B27","doi-asserted-by":"crossref","first-page":"1658001","DOI":"10.3389\/fmed.2025.1658001","article-title":"Epithelial\u2013mesenchymal transition in pulmonary fibrosis: molecular mechanisms and emerging therapeutic strategies","volume":"12","author":"Li","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"2026080400365371500_keag367-B28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/biomedicines13061463","article-title":"Predictive biomarkers and novel treatments for the progressive fibrosing phenotype in interstitial lung disease associated with connective tissue disease","volume":"13","author":"Chung","year":"2025","journal-title":"Biomedicines"},{"key":"2026080400365371500_keag367-B29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1165\/rcmb.2011-0237OC","article-title":"MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation","volume":"46","author":"Madala","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026080400365371500_keag367-B30","doi-asserted-by":"crossref","first-page":"e20230003","DOI":"10.14293\/genint.14.1.004","article-title":"Role of mitogen-activated protein (MAP) kinase pathways in metabolic diseases","volume":"15","author":"Ng","year":"2024","journal-title":"Genome Integr"},{"key":"2026080400365371500_keag367-B31","doi-asserted-by":"crossref","first-page":"109409","DOI":"10.1016\/j.intimp.2022.109409","article-title":"Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK\/ERK\/S100A4 signalling pathway","volume":"113","author":"Yang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"2026080400365371500_keag367-B32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/SHK.0000000000001960","article-title":"Fluorofenidone attenuates pulmonary inflammation and fibrosis by inhibiting the IL-11\/MEK\/ERK signaling pathway","volume":"58","author":"Song","year":"2022","journal-title":"Shock"},{"key":"2026080400365371500_keag367-B33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/ijms26010143","article-title":"Neutrophil extracellular trap formation model induced by monosodium urate and phorbol myristate acetate: involvement in MAPK signaling pathways","volume":"26","author":"Wu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026080400365371500_keag367-B34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1593\/neo.04241","article-title":"Activation of the ERK pathway is required for TGF-\u03b21-induced EMT in vitro","volume":"6","author":"Xie","year":"2004","journal-title":"Neoplasia"},{"key":"2026080400365371500_keag367-B35","doi-asserted-by":"crossref","first-page":"111886","DOI":"10.1016\/j.yexcr.2020.111886","article-title":"Inhibition of the ERK1\/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitro","volume":"391","author":"Zou","year":"2020","journal-title":"Exp Cell Res"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag367\/68970137\/keag367.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/8\/keag367\/68970137\/keag367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/8\/keag367\/68970137\/keag367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:37:07Z","timestamp":1785818227000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag367\/8735269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag367","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,15]]},"article-number":"keag367"}}